RxDoctor Payments Data

Nicole Nurse, DO

Family Medicine · Concord, CANPI 1518252477

Payments from drug & device makers

$482in general payments, 2019–2025

Across 34 payments — averaging $14.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$152
  • AstraZeneca$90
  • Novo Nordisk$56
  • Daiichi Sankyo Inc.$46
  • Genentech USA, Inc.$39
  • Merck$24
  • plus $75 from 5 others

What the payments were for

  • Food & beverage$47899%
  • Education$51%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$482 in reported general payments places this provider in the 60th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$46,926
Medicare patients
181
Services billed
680

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide26$39,609
EliquisApixaban13$20,095
LinzessLinaclotide11$10,657
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$10,069
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,943
Wixela InhubFluticasone Propion/Salmeterol11$5,280
Albuterol Sulfate HfaAlbuterol Sulfate63$3,747
Levothyroxine Sodium208$2,516
Atorvastatin Calcium191$1,934
Bupropion Hcl SrBupropion Hcl12$1,879
Estradiol12$1,819
Sertraline Hcl44$1,624
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen90$1,599
Donepezil Hcl14$1,312
SynthroidLevothyroxine Sodium16$1,281

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$56$39,60926 claims
PfizerEliquis$152$20,09513 claims
Boehringer IngelheimStiolto Respimat$21$10,06912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 10,533 family medicine providers in California.

Other family medicine in Concord

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →